Gracell Biotechnologies Inc. (GRCL) Earnings Report - Discounting Cash Flows
GRCL
Gracell Biotechnologies Inc.
GRCL (NASDAQ)
Period Ending: 2024
08-12
2024
05-13
2024
03-11
2023
11-13
2023
08-14
2023
05-15
2023
03-13
2022
11-14
2022
08-15
2022
05-16
2022
03-14
2021
11-15
2021
08-17
2021
05-17
2021
03-09
2021
01-08
2020
06-29
2020
03-30
2019
12-31
Actual EPS - - -0.30 -0.10 -0.30 -0.35 -0.30 -0.36 -0.32 -0.37 -0.30 -0.30 -0.22 -0.25 -0.16 -0.11 -0.33 -0.23 -0.31
Estimated EPS - - -0.14 -0.26 -0.37 -0.35 -0.43 -0.09 -0.08 -0.08 -0.38 -0.12 -0.05 -0.21 -0.26 - - - -
Actual Revenue - - - - - - - - - - - 0.057 - - - - - - -
Estimated Revenue - - - - - - 0.125 0.025 - - - 0.366 - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program